LogicBio Therapeutics, Inc. Operating Lease Right-of-Use Assets
LogicBio Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $3.70 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2022-11-14
- 2022-09-30: Operating Lease, Right-of-Use Asset $3.70M.
- 2022-06-30: Operating Lease, Right-of-Use Asset $4.00M.
- 2022-03-31: Operating Lease, Right-of-Use Asset $4.29M.
- 2021-12-31: Operating Lease, Right-of-Use Asset $4.57M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2022-09-30 | $3.70M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.00M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.29M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.57M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $4.85M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.13M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $5.39M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.66M 10-K · filed 2022-03-04 |
| 2020-09-30 | $5.95M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $6.29M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $199.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $504.00K 10-K · filed 2021-03-15 |
| 2019-09-30 | $669.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $967.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.26M 10-Q · filed 2019-05-14 |